-
Signature
-
/s/ Henrikki Harsu, Attorney-in-Fact for Chris Wolfe
-
Issuer symbol
-
N/A
-
Transactions as of
-
05 Aug 2021
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
09 Aug 2021, 20:44:48 UTC
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DALS |
Class B Common Stock, par value $0.0001 per share |
Disposed to Issuer |
$0 |
-18,750 |
-13% |
$0.000000 |
125,000 |
05 Aug 2021 |
Class A Common Stock |
18,750 |
|
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Henrikki Harsu, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on July 27, 2021 by Chris Wolfe.